Status:
UNKNOWN
An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Liver Abscess, Pyogenic
Liver Abscess
Eligibility:
All Genders
18+ years
Brief Summary
Pyogenic liver abscess is one of the most common visceral abscesses, its incidence is increasing worldwide. According to the previous literature, the mortality rate of pyogenic liver abscess is as hig...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age;
- Irrespective of gender;
- Symptomatic patients of liver abscess confirmed with radiology imaging, either by ultrasonography or computed tomography scan.
Exclusion
- Patients \<18 years old;
- Pregnancy at presentation.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05213949
Start Date
January 1 2022
End Date
January 1 2025
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NanFang Hospital of Southern Medical University
Guangzhou, Guangdong, China, 5100515